CADIAN CAPITAL MANAGEMENT, LP - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 153 filers reported holding ENDOLOGIX INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CADIAN CAPITAL MANAGEMENT, LP ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q3 2016$36,406,000
-27.6%
2,844,224
-29.5%
1.92%
-30.4%
Q2 2016$50,251,000
+0.4%
4,033,023
-32.7%
2.76%
-17.9%
Q1 2016$50,071,000
-10.9%
5,989,400
+5.5%
3.36%
+66.5%
Q4 2015$56,196,000
+207.1%
5,676,342
+280.3%
2.02%
+206.5%
Q3 2015$18,297,000
+23.3%
1,492,443
+54.3%
0.66%
+50.8%
Q2 2015$14,841,000967,4430.44%
Other shareholders
ENDOLOGIX INC shareholders Q3 2016
NameSharesValueWeighting ↓
Tamarack Capital Management, LLC 4,000,000$68,280,0009.00%
Essex Woodlands Management, Inc. 1,257,468$26,843,0005.32%
First Light Asset Management, LLC 277,264$4,733,0002.42%
Lisanti Capital Growth, LLC 175,060$2,988,0001.70%
ArrowMark Colorado Holdings LLC 3,150,275$53,775,0001.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,349,351$40,103,0001.30%
Rail-Splitter Capital Management, LLC 186,076$3,176,0000.97%
WASHINGTON CAPITAL MANAGEMENT, INC 82,316$1,405,0000.81%
Perceptive Advisors 565,000$9,645,0000.75%
PALISADE CAPITAL MANAGEMENT, LP 1,629,329$27,813,0000.70%
View complete list of ENDOLOGIX INC shareholders